Bausch+Lomb IPO Presentation Deck
SALONS
BIO
true
Og
SAUSCHLOS
Bio
true
TO
Bausch + Lomb U.S. contact lens share has grown by
~50% since 2017
BAUSCH LOMD
FETT
U.S. Contact Lens Market Share¹
. Continuous growing partnerships with optometry
Growing E-Commerce presence
• Sales and marketing execution
Partnerships with retailers and buying groups
BiotrueⓇ
ONEday
2012
Biotrue®
ONEday for
Presbyopia
2014
Bausch + Lomb
ULTRAⓇ
2014
BAUSCH+ LOMB
8.9%
2015
1. Third party data on file.
9.0%
2016
BAUSCH+LOMB
ULTRA gortact
Bausch + Lomb
ULTRA®
for Presbyopia
BAUSCH + LOMB
ONE by ONE
RECYCLING PROGRAM
9.7%
2017
SEVIGN LONG
Bio
true
Biotrue ONEday
for Astigmatism
BAUSCH LOMB
contact
ULTRA
Bausch+Lomb ULTRA®
for Astigmatism
11.8%
2018
12.6%
2019
BAUSCH LOMB
ULTRA
konses
Bausch + Lomb
ULTRA® Multifocal
for Astigmatism
14.0%
2020
INFUSE
VISION CARE
Bausch + Lomb
INFUSEⓇ
14.5%
2021
21View entire presentation